New hope for rare blood cancer: aggressive combo therapy shows promise

NCT ID NCT02858999

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times

Summary

This study tested a multi-step treatment plan for 40 people under 70 with primary plasma cell leukemia, a rare and aggressive blood cancer. The approach included several rounds of different chemotherapy drugs, followed by a stem cell transplant using the patient's own cells, and in some cases a donor transplant. The goal was to see if this intensive plan could help people live longer without the cancer coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HP

    Paris, 75004, France

  • CH Dunkerque

    Dunkirk, 59385, France

  • CH Pays d'Aix

    Aix-en-Provence, 13616, France

  • CHRU Lille

    Lille, 59037, France

  • CHU Amiens

    Amiens, 80054, France

  • CHU Besançon

    Besançon, 25030, France

  • CHU Caen

    Caen, 14033, France

  • CHU Clermont Ferrand

    Clermont-Ferrand, 63003, France

  • CHU Dijon

    Dijon, 21034, France

  • CHU Nancy

    Nancy, 54035, France

  • CHU Nantes

    Nantes, 44093, France

  • CHU Nice

    Nice, 06003, France

  • CHU Poitiers

    Poitiers, 86021, France

  • CHU Rennes

    Rennes, 35033, France

  • CHU Strasbourg

    Strasbourg, 67091, France

  • CHU Toulouse

    Toulouse, 31059, France

  • CHU Tours

    Tours, 37044, France

  • Hospices Civils de Lyon

    Lyon, 69229, France

Conditions

Explore the condition pages connected to this study.